Will the top two weed stocks be in the good graces of investors in 2021? Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Canopy Growth (TSX:WEED)(NASDAQ:CGC) had a nice spike on the first trading day of the year. Fresh funds of more than US$150 million entered the cannabis space in the past three months, according to Stifel GMP Analyst Andrew Parthenio.
The same analyst also said the companies are significantly undervalued compared to more mature sectors. Thus, notable earnings upside could be on the horizon. Some analysts are more upbeat following the Democrats’ twin victories in Georgia runoffs. U.S. president-elect Joe Biden could fulfill his campaign promise to decriminalize marijuana.
Right-sizing for future growth
On December 1, 2020, Aurora Cannabis shares plunged 17.2% and continued to slide. Reports that the company was pausing operations at one of its marijuana production facilities and at laying off more workers dragged the stock down. However, the price has risen to $12.67 on January 8, 2021, or 19.5% higher than its 2020 year-end price.
Despite the production cuts and mass layoffs last year, Aurora CEO Miguel Martin said there’s still plenty of money to make in the pot business. The company just needs to get through the right-sizing. He adds the cannabis industry is going through a reckoning. Opportunities might also open up in the U.S, with the decriminalization of marijuana.
People in the states of Arizona, Mississippi, Montana, New Jersey, and South Dakota, Mississippi voted in November 2020 to legalize recreational or medical cannabis. A democratic bill, the Safe Banking Act, could well pass. Once approved, financial institutions can work with cannabis companies like Aurora without retribution.
Reclaiming lost glory
Industry leader Canopy Growth didn’t have a disastrous year as you would imagine. Investors lost by 14.7%, although the stock sank to as low as $14.14 on March 18, 2020. As of January 8, 2021, WEED is trading at $38.40, or 22.6% higher than its 2020 year-end price of $31.32.
With the democrats taking control of the U.S. Senate, a rally is imminent. According to top cannabis analyst and Cohen Managing Director Vivian Azer, weed stocks could pop by more than 50% due to the impending marijuana reform. On January 4, 2021, New York Governor Andrew Cuomo called on state legislators to approve a legal marijuana framework.
Canopy Growth will significantly benefit from cannabis liberalization. In December, the Marijuana Opportunity Reinvestment and Expungement Act (MORE) passed in the U.S. House of Representatives. Cannabis is now off the list of controlled substances. The United Nations also removed cannabis from its schedule of dangerous drugs.
Back in the limelight
Weed stocks are back in the limelight after investors lost appetite in the cannabis space in the last two years. The industry outlook looks brighter as pressure to lift laws against the use of cannabis is mounting. Aurora Cannabis and Canopy Growth were the sector’s top draws until the companies reported massive losses.
However, the competition will surely grow whether there’s full legalization of marijuana or piecemeal reform in the U.S. Rivals Aphria and Tilray announced a merger. U.S.-based cannabis could also pose a serious challenge to their Canadian counterparts. Expect Canopy Growth to gain better momentum than Aurora Cannabis. American alcohol giant Constellation Brands and a Fortune 500 company has a significant stake in the industry leader.
Speaking of top weed stocks Aurora Cannabis and Canopy Growth surging at the start of 2021...
Motley Fool Canada's market-beating team has just released a brand-new FREE report revealing 5 "dirt cheap" stocks that you can buy today for under $49 a share.
Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune.
Don't miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.